» Articles » PMID: 26704623

Pelvic MRI Findings in Relapsed Prostate Cancer After Radical Prostatectomy

Overview
Journal Radiat Oncol
Publisher Biomed Central
Specialties Oncology
Radiology
Date 2015 Dec 26
PMID 26704623
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose/objective: Little is known about the clinical impact of using multiparametric MRI to plan early salvage radiotherapy after radical prostatectomy. We aimed to evaluate the incidence and location of recurrence based on pelvic multiparametric MRI findings and to identify clinical variables predictive of positive imaging results.

Materials And Methods: We defined radiological criteria of local and lymph node malignancy and reviewed records and MRI studies of 70 patients with PSA recurrence after radical prostatectomy. We performed univariate and multivariate analysis to identify any association between clinical, pathological and treatment-related variables and imaging results.

Results: Multiparametric MRI was positive in 33/70 patients. We found local and lymph node recurrence in 27 patients and 7 patients, respectively, with a median PSA value of 0.38 ng/ml. We found no statistically significant differences between patients with positive and negative multiparametric MRI for any variable. Shorter PSADT was associated with positive lymph nodes (median PSADT: 5.12 vs 12.70 months; p: 0.017).

Conclusions: Nearly half the patients had visible disease in multiparametric MRI despite low PSA. Positive lymph nodes incidence should be considered when planning salvage radiotherapy, particularly in patients with a short PSADT.

Citing Articles

Imaging assessment of prostate cancer recurrence: advances in detection of local and systemic relapse.

Muglia V, Laschena L, Pecoraro M, de Lion Gouvea G, Colli L, Panebianco V Abdom Radiol (NY). 2024; 50(2):807-826.

PMID: 39254707 DOI: 10.1007/s00261-024-04412-7.


Diagnostic yield of multiparametric MRI for local recurrence at biochemical recurrence after radical prostatectomy.

Kim M, Hwang S, Ahn H, Lee H, Byun S, Hong S Prostate Int. 2022; 10(3):135-141.

PMID: 36225284 PMC: 9520418. DOI: 10.1016/j.prnil.2022.05.001.


Detecting and Locating the Site of Local Relapse Using F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients-Potential Impact on PSMA-Guided Radiation Therapy.

Koerber S, Kroener R, Dendl K, Kratochwil C, Fink C, Ristau J Mol Imaging Biol. 2022; 25(2):375-383.

PMID: 35999425 PMC: 10006015. DOI: 10.1007/s11307-022-01766-6.


Targeting Local Recurrence After Surgery With MRI Imaging for Prostate Cancer in the Setting of Salvage Radiation Therapy.

Renard-Penna R, Zhang-Yin J, Montagne S, Aupin L, Bruguiere E, Labidi M Front Oncol. 2022; 12:775387.

PMID: 35242702 PMC: 8887697. DOI: 10.3389/fonc.2022.775387.


Predictors of prostate bed recurrence on magnetic resonance imaging in patients with rising prostate-specific antigen after radical prostatectomy.

Nasser N, Chernyak V, Shankar V, Garg M, Bodner W, Kalnicki S Can Urol Assoc J. 2020; 15(1):E22-E28.

PMID: 32701441 PMC: 7769522. DOI: 10.5489/cuaj.6463.


References
1.
Heesakkers R, Jager G, Hovels A, de Hoop B, van den Bosch H, Raat F . Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging. Radiology. 2009; 251(2):408-14. DOI: 10.1148/radiol.2512071018. View

2.
Alongi F, Fiorino C, Cozzarini C, Broggi S, Perna L, Cattaneo G . IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy. Radiother Oncol. 2009; 93(2):207-12. DOI: 10.1016/j.radonc.2009.08.042. View

3.
Giovacchini G, Picchio M, Coradeschi E, Bettinardi V, Gianolli L, Scattoni V . Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging. 2009; 37(2):301-9. DOI: 10.1007/s00259-009-1253-3. View

4.
Budiharto T, Joniau S, Lerut E, Van den Bergh L, Mottaghy F, Deroose C . Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases. Eur Urol. 2011; 60(1):125-30. DOI: 10.1016/j.eururo.2011.01.015. View

5.
Meijer H, van Lin E, Debats O, Witjes J, Span P, Kaanders J . High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2011; 82(4):1405-10. DOI: 10.1016/j.ijrobp.2011.04.054. View